• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolecarboxylic acids and derivatives

Ethyl 6-bromo-1H-indole-3-carboxylate (CAS No. 103858-55-5): A Comprehensive Overview

Ethyl 6-bromo-1H-indole-3-carboxylate (CAS No. 103858-55-5) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has been extensively studied for its potential applications in drug discovery and development. The 6-bromo substitution on the indole ring and the ethyl ester functionality make it a valuable intermediate in the synthesis of various bioactive molecules.

The indole scaffold is a fundamental building block in many natural products and pharmaceuticals, known for its diverse biological activities. The presence of the 6-bromo group in Ethyl 6-bromo-1H-indole-3-carboxylate introduces additional reactivity and selectivity, which can be harnessed to synthesize compounds with enhanced pharmacological properties. Recent studies have highlighted the importance of brominated indoles in the development of novel therapeutics, particularly in areas such as oncology, neurology, and infectious diseases.

In the context of medicinal chemistry, Ethyl 6-bromo-1H-indole-3-carboxylate serves as a key intermediate in the synthesis of indole-based drugs. The ethyl ester group can be readily converted to various functional groups, such as carboxylic acids, amides, and hydrazides, through well-established chemical transformations. This flexibility allows researchers to explore a wide range of structural modifications to optimize the pharmacokinetic and pharmacodynamic properties of the final drug candidates.

One notable application of Ethyl 6-bromo-1H-indole-3-carboxylate is in the development of selective serotonin reuptake inhibitors (SSRIs). SSRIs are widely used to treat depression and anxiety disorders, and the indole scaffold is a common feature in many SSRI molecules. The 6-bromo substitution has been shown to enhance the binding affinity of these compounds to serotonin transporters, potentially leading to more effective therapeutic outcomes with fewer side effects.

Additionally, Ethyl 6-bromo-1H-indole-3-carboxylate has been investigated for its potential as an anticancer agent. Indoles with bromine substitutions have demonstrated significant antiproliferative activity against various cancer cell lines. The mechanism of action is thought to involve the modulation of key signaling pathways involved in cell growth and survival. For example, recent studies have shown that brominated indoles can inhibit the PI3K/AKT/mTOR pathway, which is frequently dysregulated in cancer cells.

The synthesis of Ethyl 6-bromo-1H-indole-3-carboxylate typically involves a multi-step process that begins with the formation of an indole derivative followed by bromination and esterification reactions. The choice of starting materials and reaction conditions can significantly impact the yield and purity of the final product. Advanced synthetic techniques, such as transition-metal-catalyzed cross-coupling reactions, have been employed to improve the efficiency and scalability of these syntheses.

In addition to its role as a synthetic intermediate, Ethyl 6-bromo-1H-indole-3-carboxylate has also been studied for its potential as a probe molecule in biological assays. The bromine atom can be used as a handle for further functionalization or labeling, allowing researchers to track the compound's behavior within cells or tissues. This property makes it useful for studying protein-protein interactions, receptor binding kinetics, and other fundamental biological processes.

The safety profile of Ethyl 6-bromo-1H-indole-3-carboxylate is an important consideration for both laboratory use and potential clinical applications. While this compound is generally considered safe when handled under appropriate conditions, proper precautions should be taken to avoid exposure to skin or inhalation. Toxicological studies have shown that it exhibits low acute toxicity but may have long-term effects at high concentrations or prolonged exposure.

In conclusion, Ethyl 6-bromo-1H-indole-3-carboxylate (CAS No. 103858-55-5) is a valuable compound with broad applications in medicinal chemistry and pharmaceutical research. Its unique structural features make it an attractive candidate for the development of novel therapeutics targeting various diseases. Ongoing research continues to uncover new insights into its biological activities and synthetic potential, further solidifying its importance in the field.

• 773873-77-1(Methyl 5-bromo-1H-indole-3-carboxylate)
• 868656-97-7(Methyl 6-bromo-1H-indole-3-carboxylate)
• 1224724-39-3(Methyl 4-bromo-1H-indole-7-carboxylate)
• 1226762-74-8(Ethyl 7-bromoquinoline-3-carboxylate)
• 101909-43-7(Methyl 4-bromo-1H-indole-3-carboxylate)
• 481054-89-1(Ethyl 6-bromoquinoline-3-carboxylate)
• 1033265-51-8(Tert-Butyl 5-bromo-1H-indole-3-carboxylate)
• 1065181-58-9(Ethyl 5-bromo-1H-indole-7-carboxylate)
• 959239-01-1(Methyl 7-Bromo-1h-indole-3-carboxylate)
• 1383551-36-7(ethyl 5-bromoquinoline-3-carboxylate)